Home / People / Stefan-Ulrich Müller
Stefan-Ulrich Müller

Stefan-Ulrich Müller, M. Jur. (Oxford)

Partner
Rechtsanwalt

CMS Hasche Sigle
Nymphenburger Straße 12
80335 Munich
Germany
Languages German, English

Stefan-Ulrich Müller specialises in domestic and cross-border venture capital, growth capital and M&A transactions. He advises financial investors, strategic investors as well as tech companies and management teams throughout the whole process from investment to exit. His practice – which clients highly recommend in various legal industry publications – in particular includes advising on investments and rounds of financing, corporate governance, venture debt as well as on the sale or IPO of the company. He also advises frequently on management and employee participations.

Stefan has special sector expertise in biotech and medtech and also with software and ecommerce companies.

He advises selected start-ups through the CMS equIP programme.

He joined CMS in 1995 and became a partner in 2000. Jointly with Jörg Zätzsch, he heads the CMS “Venture Capital Excellence Cluster“.

more less

„sehr erfahrener und besonnener Experte“

The Legal 500 Deutschland, 2020

"He always finds a very creative solution and good compromise suggestions. He is very calm and composed."

Chambers Europe, 2019

Relevant experience


Investments

  • 2015: Advising LSP Life Sciences Partners on their investment in Luxendo
  • 2015: Advising Outfittery on USD 20 million round of financing
  • 2015: Advising Forbion Capital Partners and Sunstone Life Science Ventures on their investment in Rigontec
  • 2014: Advising invendo medical on EUR 20 million round of financing
  • 2014: Advising eGym on USD 15 million round of financing
  • 2013: Advising Immatics Biotechnologies on EUR 34 million investment round

Trade sales

  • 2015: Advising Earlybird Venture Capital and founders on the sale of carpooling.com to BlaBlaCar
  • 2015: Advising MIG, BioMedInvest and BayernKapital, among others on the sale of SuppreMol to Baxter; volume: EUR 200 million
  • 2014: Advising Gilde Healthcare on the sale of Definiens to MedImmune/AstraZeneca; volume: USD 150 million upfront plus milestone payments
  • 2014: Advising Sapiens Steering Brain Stimulation in the context of its sale to Medtronic; volume: EUR 150 million

IPOs

  • 2015: Advising Curetis on Euronext Amsterdam/Brussels IPO, including pre-IPO financing
  • 2014: Advising Affimed on Nasdaq Global Market IPO, including pre-IPO financing and venture debt
more less

Education


  • 1996: Magister Juris in European and Comparative Law, Magdalen College, University of Oxford
  • 1992 - 1994: Research assistant of Prof. Dr. Claus-Wilhelm Canaris at the Institute of Civil Law and Civil Procedure Law of the University of Munich
  • Trainee lawyer in the Higher Regional Court of Munich district
  • Law studies at the University of Munich and the University of Oxford
more less

Feed

Show only
06/08/2020
One of the largest bi­otech fin­an­cing rounds in Ger­many in re­cent years:...
Mu­nich – T-knife GmbH, a bi­otech start-up op­er­at­ing in the field of T-cell ther­apy against can­cer, has com­pleted a EUR 66 mil­lion Series A fin­an­cing round. The round was led by highly re­garded US in­vestors...
19/03/2020
CMS ad­vises bi­otech com­pany Im­mat­ics Bi­o­tech­no­lo­gies on mer­ger with Arya...
Mu­nich – Im­mat­ics Bi­o­tech­no­lo­gies GmbH, which is based in Tübin­gen, Mu­nich and Hou­s­ton/Texas, has an­nounced a mer­ger with Arya Sci­ences Ac­quis­i­tion Corp. Once com­pleted, the mer­ger will make new funds...
13/02/2020
CMS ad­vises LEA Part­ners on seed fin­an­cing round for em­ploy­ee app Flip
Mu­nich – Stut­tgart-based start-up Flip has raised around EUR 3.6 mil­lion for its em­ploy­ee app in a seed round of fin­an­cing. Es­tab­lished in 2018, the start-up has de­veloped an app that provides com­pan­ies...
08/07/2019
CMS ad­vises on spin-off and fin­an­cing of Break­point Thera­peut­ics GmbH
Mu­nich – Evotec SE, a drug dis­cov­ery and de­vel­op­ment com­pany, has es­tab­lished Break­point Thera­peut­ics GmbH as a spin-off. The new com­pany holds a port­fo­lio of pro­jects for de­vel­op­ing on­co­logy drugs...
29/05/2019
CMS ad­vises per­son­al shop­ping ser­vice Out­fit­tery on mer­ger with Modo­moto
Mu­nich – Ber­lin-based com­pan­ies Out­fit­tery and the Cur­ated Shop­ping Group (which in­cludes the Modo­moto brand) are mer­ging to form Europe’s largest per­son­al shop­ping pro­vider. Go­ing for­ward, the com­pany...
15/05/2019
CMS ad­vises CY­N­ORA on Series C round of fin­an­cing
Mu­nich – cy­n­ora GmbH, a ma­ter­i­als man­u­fac­turer in the dis­play in­dustry, has re­ceived an ad­di­tion­al USD 25 mil­lion from in­vestors in Asia, Europe and the US in a first clos­ing of its Series C fin­an­cing...
24/04/2019
CMS ad­vises tech­no­logy in­vestor LEA Part­ners on ven­ture cap­it­al fin­an­cing...
Mu­nich – Quant­itec, a de­veloper of real-time loc­al­isa­tion tech­no­lo­gies, has re­ceived growth cap­it­al of EUR 3.9 mil­lion in a ven­ture cap­it­al fin­an­cing round. The round was led by LEA Part­ners. Oth­er...
03/12/2018
CMS ad­vises Wel­ling­ton and HBM as lead in­vestors in Series D round of fin­an­cing...
Mu­nich – Ad­renomed AG, a bio­phar­ma­ceut­ic­al com­pany spe­cial­ising in the in­teg­rity and bar­ri­er func­tion of blood ves­sels, has com­pleted a EUR 24 mil­lion Series D fin­an­cing round co-led by Wel­ling­ton Part­ners...
19/11/2018
CMS ad­vises share­hold­ers in soft­ware se­cur­ity start-up Pro­tec­ted Net­works...
Mu­nich – High-Tech Gründer­fonds, Mile­stone Ven­ture Cap­it­al and the com­pany’s founders have sold their shares in Pro­tec­ted Net­works to Sol­ar­Winds. The Ber­lin-based start-up was es­tab­lished in 2009...
30/10/2018
CMS ad­vises tado° on new fin­an­cing round worth USD 50 mil­lion
Mu­nich – Tech­no­logy com­pany tado GmbH has com­pleted an­oth­er in­ter­na­tion­al round of fin­an­cing worth a total of USD 50 mil­lion. New in­vestors in­clude Amazon, E.ON, Total En­ergy Ven­tures, En­ergy In­nov­a­tion...
14/09/2018
CMS ad­vises share­hold­ers in as­sist­ance sys­tems de­veloper Sem­Vox on sale...
Stut­tgart – The share­hold­ers in Sem­Vox GmbH have signed an agree­ment on the sale of 82% of their shares in the com­pany to par­agon GmbH & Co. KGaA. Ac­quir­ing Sem­Vox GmbH gives par­agon GmbH & Co. KGaA...
01/08/2018
CMS ad­vises Cir­cu­lar­ity Cap­it­al on in­vest­ment in Ber­lin-based Grover
Mu­nich – Ber­lin-based Grover has com­pleted a Series A round of fin­an­cing totalling EUR 37 mil­lion. The fin­an­cing round com­prises a total of EUR 12 mil­lion from equity pro­viders and a fur­ther EUR 25...